V8 Transluminal Balloon Aortic Valvuloplasty Catheter
by Intervalve, Inc. 4 variants
510(k) K132728
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK132728 | Date22 Nov 2013 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- V8 Transluminal Bav Catheter
- 510(k) Number
- FDA Product Code
- OZT
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1255
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 20 Sep 2026
The V8 Transluminal Balloon Aortic Valvuloplasty Catheter is a Balloon Aortic Valvuloplasty device, designed to mechanically dilate a stenotic aortic valve via transluminal balloon inflation. It is intended for use in percutaneous interventions to improve blood flow through a narrowed aortic valve, typically in patients with aortic stenosis.
This catheter is supplied as a single-use, sterile device and is classified as a Class 2 medical device under FDA regulations (product code OZT). It is cleared through the FDA 510(k) pathway and is intended for use in controlled clinical settings, such as cardiac catheterization labs. The device is regulated under 21 CFR 870.1255 and requires proper handling, storage, and disposal in accordance with medical device guidelines.
Other devices from Intervalve, Inc.
Questions
AI-generated answers, 20 Sep 2026
What is the primary clinical purpose of the V8 Transluminal BAV Catheter, and in which setting is it typically used?
The V8 Transluminal BAV Catheter is designed to mechanically widen a narrowed aortic valve (aortic stenosis) by inflating a balloon inside the valve during a percutaneous procedure. It is intended for use in cardiac catheterization labs, where interventional cardiologists perform controlled, minimally invasive interventions to improve blood flow through the aortic valve in patients with severe stenosis.
Is the V8 Transluminal BAV Catheter intended for single-use or repeated use, and how should it be handled to maintain sterility?
The device is explicitly supplied as a single-use catheter and comes sterile. To preserve sterility, it must be handled using aseptic techniques—only opened immediately before use, stored in its original packaging until deployment, and disposed of properly after one procedure to prevent contamination or reuse.
What regulatory pathway was used to clear this device, and which FDA guidelines govern its use?
The V8 Transluminal BAV Catheter was cleared through the FDA 510(k) pathway, specifically under Special Clearance (K132728) and classified as a Class 2 device (product code OZT). It is regulated under 21 CFR 870.1255, which mandates adherence to proper handling, storage, and disposal protocols in clinical settings.
Are there multiple sizes or models of the V8 Transluminal BAV Catheter, and if so, how are they differentiated?
The device data lists multiple FEI numbers (Foreign Entity Identification) and registration numbers, which typically correspond to different catheter sizes or configurations (e.g., balloon diameters or shaft lengths). While exact specifications (e.g., nominal diameters) aren’t detailed here, these identifiers imply the manufacturer offers a range of sizes to accommodate varying patient anatomies or procedural needs. For precise sizing, refer to the device’s labeling or manufacturer’s instructions.